In correct I've talked about this many times, when companies management teams screw up as evident by Generex management teams all gone now it is something call d blown assets in pharma, we've managed to rekindle some old assets because they are that good, however OL is a different story, as I've said many companies are infringing on our patents to many to count and I will go after them as I've said, OL to get proof of concept in type 2 we have to do monome will do it for you unless they steal it for dirt cheap, so stick to the plan I layed out, buy Companies get to substantial revenue through acquisitions and pay for our own development need in OL, not very smart right now to raise 15 million bucks just for OL and focus on blown assets. I've said this before in conference calls, pfizer exuberant was a blown asset they will never bring that back, why because mankind is a dog, OL will get the light of day one day as I've said before.
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links